Abstract
Background
Pulmonary interstitial glycogenosis is a form of childhood interstitial lung disease characterized by the histological finding of abundant glycogen-laden mesenchymal cells within the pulmonary interstitium. Patients present in the neonatal period with disproportionate respiratory distress. Often, pulmonary interstitial glycogenosis is accompanied by alveolar simplification complicating recognition and diagnosis. Despite the recognition of pulmonary interstitial glycogenosis as a distinct entity, only a few case reports describing imaging findings are found in the literature, with no published systematic review available.
Objective
The purpose of this review is to provide a review of CT findings of pulmonary interstitial glycogenosis with histological correlation to aid in early diagnosis and management.
Materials and methods
A 10-year retrospective review was performed to identify pediatric patients <18 years who underwent biopsy and CT within the last 10 years at our institution. The inclusion criteria include patients who had a CT within 3 months of biopsy and pathology-proven pulmonary interstitial glycogenosis CTs that were evaluated by three radiologists using a standardized scoring system.
Results
Fifteen patients met inclusion criteria (9 male, 6 female). At the time of initial pre-biopsy CT, ages ranged from 2 weeks to 5 months. Pulmonary symptoms presented at birth in the majority of patients (n=13). Two patients presented in early infancy at 3 months (n=1) and 5 months (n=1). Ground glass opacities were the most common CT finding (n=14), which varied from diffuse to scattered. Cystic lucencies (n=11) were noted in the majority of patients as well. Interlobular septal thickening (n=10) and architectural distortion (n=8) were less common findings.
Conclusion
The most common CT findings of pulmonary interstitial glycogenosis are ground glass opacities with cystic lucencies. While the imaging findings are distinct from the typical presentation of neuroendocrine hyperplasia of infancy, there is significant overlap of these findings with surfactant dysfunction mutations, entities that also present with respiratory distress in the neonatal period. Therefore, imaging findings in pulmonary interstitial glycogenosis are helpful in guiding the need for genetic testing and/or biopsy.
Similar content being viewed by others
References
Fan LL, Deterding RR, Langston C (2004) Pediatric interstitial lung disease revisited. Pediatr Pulmonol 38:369–378
Deutsch GH, Young LR, Deterding RR et al (2007) Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 176:1120–1128
Dishop MK (2010) Diagnostic pathology of diffuse lung disease in children. Pediatr Allergy Immunol Pulmonol 23:69–85
Kurland G, Deterding RR, Hagood JS et al (2013) An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 188:376–394
Canakis A-M, Cutz E, Manson D et al (2002) Pulmonary interstitial glycogenosis. Am J Respir Crit Care Med 165:1557–1565
Brody AS, Guillerman RP, Hay TC et al (2010) Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. AJR Am J Roentgenol 194:238–244
Lanfranchi M, Allbery SM, Wheelock L et al (2010) Pulmonary interstitial glycogenosis. Pediatr Radiol 40:361–365
Castillo M, Vade A, Lim-Dunham JE et al (2010) Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation. Pediatr Radiol 40:1562–1565
Weinman JP, Manning DA, Liptzin DR et al (2017) HRCT findings of childhood follicular bronchiolitis. Pediatr Radiol 47:1759–1765
Engeler C, Tashjian J, Trenkner S et al (1993) Ground-glass opacity of the lung parenchyma: a guide to analysis with high-resolution CT. Am J Radiol 160:249–251
Hansell DM, Bankier AA, MacMahon H et al (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722
Haran Jogeesvaran K, Owens CM (2010) Chronic diseases of lung parenchyma in children: the role of imaging. Pediatr Radiol 40:850–858
Howling SJ, Northway WH, Hansell DM et al (2000) Pulmonary sequelae of bronchopulmonary dysplasia survivors: high-resolution CT findings. Am J Radiol 174:1323–1326
Newman B, Kuhn JP, Kramer SS et al (2001) Congenital surfactant protein B deficiency--emphasis on imaging. Pediatr Radiol 31:327–331
Hugosson CO, Salama HM, Al-Dayel F et al (2005) Primary alveolar capillary dysplasia (acinar dysplasia) and surfactant protein B deficiency: a clinical, radiological and pathological study. Pediatr Radiol 35:311–316
Herman TE, Nogee LM, McAlister WH et al (1993) Surfactant protein B deficiency: radiographic manifestations. Pediatr Radiol 23:373–375
Doan ML, Guillerman RP, Dishop MK et al (2008) Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 63:366–373
Galambos C, Levy H, Cannon CL et al (2010) Pulmonary pathology in thyroid transcription factor-1 deficiency syndrome. Am J Respir Crit Care Med 182:549–554
Deterding RR, Pye C, Fan LL et al (2005) Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol 40:157–165
Rauch D, Wetzke M, Reu S et al (2016) Persistent tachypnea of infancy: usual and aberrant. Am J Respir Crit Care Med 193:438–447
Kerby GS, Wagner BD, Popler J et al (2013) Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol 48:1008–1015
Deutsch GH, Young LR (2009) Histologic resolution of pulmonary interstitial glycogenosis. Pediatr Dev Pathol 12:475–480
Young LR, Deutsch GH, Bokulic RE et al (2013) A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy. Chest 144:1199–1206
Avital A, Hevroni A, Godfrey S et al (2014) Natural history of five children with surfactant protein C mutations and interstitial lung disease. Pediatr Pulmonol 49:1097–1105
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. R. R. Deterding discloses the following: cofounder and board member of Triple Endoscopy Inc., patent on novel endoscopy scope, and advisory board of Pediatric Interstitial Lung Disease for Boehringer Ingelheim.
Rights and permissions
About this article
Cite this article
Weinman, J.P., White, C.J., Liptzin, D.R. et al. High-resolution CT findings of pulmonary interstitial glycogenosis. Pediatr Radiol 48, 1066–1072 (2018). https://doi.org/10.1007/s00247-018-4138-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-018-4138-4